|
293 Companies |
|
491 Products |
|
491 Products |
|
198 Mechanisms of Action |
|
26 Trials |
|
7806 News |
|
| «12...145146147148149150151152153154155156157 |
- ||| Trial completion: Assessment of Patient Use of a New Device: RebiSmart (clinicaltrials.gov) - Aug 9, 2011
P=N/A, N=63, Completed, Sponsor: Merck KGaA
Active, not recruiting --> Completed
- Stem cell educator therapy / Sinobioway
New P1/2 trial: Stem Cell Educator Therapy in Type 2 Diabetes (clinicaltrials.gov) - Aug 9, 2011
P1/2, N=25, Completed, Sponsor: University of Illinois at Chicago
- tabalumab (LY2127399) / Eli Lilly
Enrollment closed: A Study of Japanese Rheumatoid Arthritis Participants (clinicaltrials.gov) - Aug 9, 2011
P1, N=32, Active, not recruiting, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Pharmacology of Insulin Injected With Jet-Injection (clinicaltrials.gov) - Aug 9, 2011
P=N/A, N=48, Completed, Sponsor: Radboud University
Recruiting --> Active, not recruiting Not yet recruiting --> Completed
- oral insulin (ORMD-0801) / Oramed
Trial completion: Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients (clinicaltrials.gov) - Aug 9, 2011
P2, N=12, Completed, Sponsor: Hadassah Medical Organization
Not yet recruiting --> Completed Not yet recruiting --> Completed
- Enrollment change: VAART: Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis (clinicaltrials.gov) - Aug 8, 2011
P4, N=140, Active, not recruiting, Sponsor: N.M. Wulffraat
Not yet recruiting --> Completed N=280 --> 140
- trichuris suis ova (CNDO-201) / Fortress
New P2 trial: TRIOMS: Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome (clinicaltrials.gov) - Aug 8, 2011
P2, N=50, Recruiting, Sponsor: Charite University, Berlin, Germany
- Enrollment closed: VAART: Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Juvenile Idiopathic Arthritis (clinicaltrials.gov) - Aug 8, 2011
P4, N=140, Active, not recruiting, Sponsor: N.M. Wulffraat
N=280 --> 140 Recruiting --> Active, not recruiting
- Trial completion: Pain and Stress Management for People With Rheumatoid Arthritis (clinicaltrials.gov) - Aug 8, 2011
P2, N=280, Completed, Sponsor: Wayne State University
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial withdrawal: Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=90, Withdrawn, Sponsor: Nanjing University School of Medicine
Active, not recruiting --> Completed Recruiting --> Withdrawn
- Rebif (human IFN-β-1a) / EMD Serono
Enrollment change: ReNew: Post Marketing Surveillance Study to Evaluate the Tolerability of Rebif® New Formulation in Patients With Relapsing Multiple Sclerosis in an Australian Clinical Setting. (clinicaltrials.gov) - Aug 7, 2011
P=N/A, N=50, Active, not recruiting, Sponsor: Merck KGaA
Recruiting --> Withdrawn N=100 --> 50
- New P1/2 trial: ETIMS: Establish Tolerance In MS With Peptide-Coupled, Peripheral Blood Mononuclear Cells (clinicaltrials.gov) - Aug 7, 2011
P1/2, N=9, Active, not recruiting, Sponsor: Universitätsklinikum Hamburg-Eppendorf
- Rebif (human IFN-β-1a) / EMD Serono, Multiferon (interferon alpha) / SOBI, Betaseron (IFN-β-1b) / Bayer
Trial completion: REPAIR: REsPonse to Interferon-Alpha in InterfeRon-β Neutralizing Antibody Positive Multiple Sclerosis Patients (clinicaltrials.gov) - Aug 7, 2011
P2, N=10, Completed, Sponsor: Melinda Magyari
N=100 --> 50 Recruiting --> Completed
- ||||||| Humira (adalimumab) / Eisai, AbbVie
Trial completion: A Study of Adalimumab in Japanese Subjects With Rheumatoid Arthritis (clinicaltrials.gov) - Aug 7, 2011
P3, N=334, Completed, Sponsor: Abbott
Recruiting --> Completed Active, not recruiting --> Completed
- dexamethasone / Generic mfg., prednisone / Generic mfg.
Trial completion: Test Predicting Adrenal Insufficiency in Volunteers Under Prednisone Treatment (clinicaltrials.gov) - Aug 7, 2011
P4, N=39, Completed, Sponsor: University Hospital, Basel, Switzerland
Active, not recruiting --> Completed Recruiting --> Completed
- | Ilaris (canakinumab) / Novartis
Trial completion: Safety, Efficacy and Pharmacokinetics of Subcutaneous ACZ885 in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) (clinicaltrials.gov) - Aug 7, 2011
P1/2, N=26, Completed, Sponsor: Novartis
Recruiting --> Completed Active, not recruiting --> Completed